✦ LIBER ✦

An Evaluation of Total Disintegration Time for Three Different Doses of Sublingual Fentanyl Tablets in Patients with Breakthrough Pain

✍ Scribed by Nalamachu, Srinivas

Book ID: 121593110
Publisher: Springer Healthcare Communications
Year: 2013
Tongue: English
Weight: 359 KB
Volume: 2
Category: Article
ISSN: 2193-8237
DOI: 10.1007/s40122-013-0019-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and Safety of Sublingual Fentan

Efficacy and Safety of Sublingual Fentanyl Orally Disintegrating Tablets in Patients with Breakthrough Pain: Multicentre Prospective Study

✍ Guitart, Jordi; Vargas, Isabel; Sanctis, Vicente; Ferreras, Julia; Fuentes, Jose 📂 Article 📅 2013 🏛 Springer International Publishing AG 🌐 English ⚖ 788 KB

Efficacy and safety of sublingual fentan

Efficacy and safety of sublingual fentanyl orally disintegrating tablet at doses determined by titration for the treatment of breakthrough pain in Japanese cancer patients: a multicenter, randomized, placebo-controlled, double-blind phase III trial

✍ Shimoyama, Naohito; Gomyo, Ikuo; Katakami, Nobuyuki; Okada, Masakuni; Yukitoshi, 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 282 KB

Fentanyl buccal tablet vs oxycodone imme

Fentanyl buccal tablet vs oxycodone immediate-release for the management of breakthrough pain in opioid-tolerant patients with chronic pain: patient disposition and dose titration

✍ M. Ashburn; K. Slevin; J. Messina; F. Xie 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 38 KB

(772): Patient preference for fentanyl b

(772): Patient preference for fentanyl buccal tablet (FBT) in the management of breakthrough pain: Open-label evaluation in opioid-tolerant patients with chronic noncancer pain

✍ S. Nalamachu; F. Xie; J. Messina 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 41 KB

Long-Term Safety and Tolerability of Fen

Long-Term Safety and Tolerability of Fentanyl Buccal Tablet for the Treatment of Breakthrough Pain in Opioid-Tolerant Patients with Chronic Pain: An 18-Month Study

✍ Perry G. Fine; John Messina; Fang Xie; James Rathmell 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 694 KB

A Novel 12-Week Study, with Three Random

A Novel 12-Week Study, with Three Randomized, Double-Blind Placebo-Controlled Periods to Evaluate Fentanyl Buccal Tablets for the Relief of Breakthrough Pain in Opioid-Tolerant Patients with Noncancer-Related Chronic Pain

✍ John T. Farrar; John Messina; Fang Xie; Russell K. Portenoy 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 737 KB